BioSpace News Archive

The consistent prevalence of chronic diseases like kidney disorders and urinary tract infections along with the influx of various cutting-edge technologies will accelerate the demand for test strips.

Consistent adoption to offer better care and treatment on account of the rising incidences of comorbidities will anchor the tubeless insulin pump market forecast.

BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that it appointed Ms. Brenda Castrodad to lead its Human Resources department.

Renibus Therapeutics, Inc., a clinical-stage biotech company focusing on the prevention, treatment, and diagnostic testing of kidney disease, announced today the publication of a peer-reviewed article in the scientific journal Nephrology Dialysis Transplant

Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal imbalance, today announced a collaboration with Ciitizen, a Palo Alto based healthcare technology company

Front Line Medical Technologies, Inc. has received Health Canada approval for its COBRA-OS™ (Control of Bleeding, Resuscitation, Arterial Occlusion System) device after three years of research and development. The COBRA-OS™ is an innovative, easy-to-use aortic occlusion device with an extremely low-profile for temporary hemorrhage control and resuscitation.

Thousands of retailers nationwide support MDA’s fundraising campaign to transform the lives of people living with muscular dystrophy, ALS and related neuromuscular diseases throughout February and March.

Menarini Silicon Biosystems, a pioneer of liquid biopsy and single cell technologies, announced today the launch of its innovative CellMag product line f

Insightec®, a global healthcare company focused on creating the next generation of patient care, announced it received market approval by the Brazilian Health Regulatory Agency, ANVISA, and is partnering with Strattner to bring Focused Ultrasound to the Brazilian market.

Dr. Richard Rosenfield’s Pearl Surgicenter embraces Value Based Healthcare, providing reduced cost, high valued surgery to women in the Portland Metropolitan Service area and beyond.